drugset / Trial / NCT00223743
A Safety/Efficacy Trial of Zonisamide for Essential Tremor
Phase 2
Completed
25 enrolled
VA Greater Los Angeles Healthcare System
Ralph M. Parsons Foundation · collab
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this pilot study is to obtain information whether the medication zonisamide reduces tremor in persons with essential tremor and is well tolerated.
Timeline
- Start
- 2004-11
- Primary completion
- 2008-09
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Zonisamide | Other / unclassified | 300 mg | — |